Rhythm

CathVision Announces Key Milestones in Advance of ECGenius Commercial Launch

ECGenius System & CARDIALYTICS Suite Recognized as Critical to the Evolution of Electrophysiology COPENHAGEN, Denmark, March 28, 2023 /PRNewswire/ — CathVision, a medical technology company developing innovative electrophysiology solutions designed to enhance clinical decision-making in the EP lab, is proud to announce the achievement of significant milestones demonstrating both the clinical and commercial […]

Biobeat’s Chest Patch and Remote Patient Monitoring Platform Demonstrate Capability as a Pre-Symptomatic and Real-Time Detection and Warning Tool for Patient Deterioration

Peer-reviewed study published in Frontiers of Physiology presents the use of Biobeat’s chest patch and novel warning score (MPRT-WS) to predict patient outcomes MPRT-WS more accurate in stratifying patients at risk of deterioration than the clinically-used National Early Warning Score (NEWS) Biobeat to host a demo booth (#2037) at ‎ViVE® 2023 from March […]

MEDINBOX PARTNERS WITH ABBOTT TO IMPROVE CONNECTIONS AND INFORMATION SHARING BETWEEN PHYSICIANS IN ELECTROPHYSIOLOGY LABS WORLDWIDE

EnSite™ Connected Care from Abbott will integrate with Medinbox’s smart video collaboration system to provide electrophysiologists with remote, real-time audiovisual support to improve case results Abbott’s exclusive global distribution agreement in electrophysiology market consolidates Medinbox’s position as major player in live medical collaboration and hospital digitization Toulouse, France, March 27, […]

New Data Demonstrates vMap’s Use Associated with Significantly Improved Outcomes in Atrial Fibrillation Treatment Study

Targeted, driver-site ablation in conjunction with pulmonary vein isolation (PVI) achieves 87.5% freedom from atrial fibrillation (AF) and atrial tachycardia (AT) in complex AF patients versus 58.0% for PVI-only control SAN DIEGO–(BUSINESS WIRE)–Vektor Medical, developer of the world’s only technology to rapidly map arrhythmias using just 12-lead ECG data, today […]

Aziyo Biologics Provides Update on FDA Submission for CanGaroo® RM Antibacterial Envelope

SILVER SPRING, Md., March 20, 2023 (GLOBE NEWSWIRE) — Aziyo Biologics, Inc. (Nasdaq: AZYO), a company that develops and commercializes biologic products to improve compatibility between medical devices and the patients who need them, provides an update on its submission to the U.S. Food and Drug Administration (FDA) for the […]

Broward Health Medical Center the First Hospital in Florida Using Advanced Genesis Robotic Technology to Treat Heart Rhythm Disorders

ST. LOUIS, March 20, 2023 (GLOBE NEWSWIRE) — Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced the grand opening of a new robotic electrophysiology program at Broward Health Medical Center in Fort Lauderdale, Florida. Broward Health is among the first in the […]

Medtronic receives CE Mark approval for Affera™ Mapping and Ablation System to treat atrial arrhythmias

First of its kind, all-in-one Sphere-9™ Catheter with pulsed field ablation, radiofrequency, and high density mapping integrated with intuitive mapping and navigation platform DUBLIN, March 15, 2023 /PRNewswire/ — Medtronic (NYSE:MDT) announced today that it has received CE (Conformité Européenne) Mark for the Affera™ Mapping and Ablation System, which includes the Sphere-9™ […]

Kardium Announces First Patients Treated in PULSAR IDE Study of Globe® Pulsed Field System

VANCOUVER, British Columbia–(BUSINESS WIRE)–Kardium Inc., a private medical device company that has developed the Globe® PF System for the treatment of atrial fibrillation (AF) using pulsed field ablation (PFA), announced today that the first patients have been successfully treated in its PULSAR clinical study. The international, multicenter study recently received U.S. Food and […]

HeartBeam Announces Acquisition of LIVMOR Assets

Extends HeartBeam’s Reach with FDA-cleared Halo+™ Atrial Fibrillation Detection System and Physician-prescribed Integrated Patient Care Platform SANTA CLARA, Calif.–(BUSINESS WIRE)–HeartBeam, Inc. (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector electrocardiogram (VECG) platform for heart attack detection anytime, anywhere, today announced the strategic acquisition of substantially […]

Acesion Pharma announces positive phase 2 data from Atrial Fibrillation clinical trial – primary endpoint achieved

First-in-class SK channel inhibition proof of mechanism achieved First new approach to treating Atrial Fibrillation for 20 years COPENHAGEN, Denmark, March 14, 2023 /PRNewswire/ — Acesion Pharma (“Acesion”), the biotech pioneering first-in-class novel therapies for Atrial Fibrillation (“AF”), the most common cardiac arrhythmia, today announced positive data from its Phase 2 trial of […]